T细胞急性淋巴细胞白血病和T细胞非霍奇金淋巴瘤的免疫疗法。 - Suppr

Suppr

超能文献

Immunotherapy for T-Cell ALL and T-Cell NHL.

作者信息

DiPersio John F, Staser Karl, Cooper Matthew

机构信息

Division of Oncology, Washington University School of Medicine, St Louis, MO, USA.

出版信息

Clin Lymphoma Myeloma Leuk. 2020 Sep;20 Suppl 1:S56-S58. doi: 10.1016/S2152-2650(20)30462-6.

DOI:10.1016/S2152-2650(20)30462-6

PMID:32862870

Abstract

摘要

相似文献

Immunotherapy for T-Cell ALL and T-Cell NHL.

Clin Lymphoma Myeloma Leuk. 2020 Sep;20 Suppl 1:S56-S58. doi: 10.1016/S2152-2650(20)30462-6.

Bispecific T-Cell Engager (BiTE) Antibody Construct Blinatumomab for the Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma: Final Results From a Phase I Study.

J Clin Oncol. 2016 Apr 1;34(10):1104-11. doi: 10.1200/JCO.2014.59.1586. Epub 2016 Feb 16.

CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies.

Blood. 2017 Jul 20;130(3):285-296. doi: 10.1182/blood-2017-01-761320. Epub 2017 May 24.

Head-to-head comparison of in-house produced CD19 CAR-T cell in ALL and NHL patients.

J Immunother Cancer. 2020 Mar;8(1). doi: 10.1136/jitc-2019-000148.

Activated T-cell-mediated immunotherapy with a chimeric receptor against CD38 in B-cell non-Hodgkin lymphoma.

J Immunother. 2009 Sep;32(7):737-43. doi: 10.1097/CJI.0b013e3181adaff1.

Chimeric antigen receptor T cells (CAR-T) for the treatment of T-cell malignancies.

Best Pract Res Clin Haematol. 2019 Dec;32(4):101097. doi: 10.1016/j.beha.2019.101097. Epub 2019 Oct 18.

T-Lymphoblastic Leukemia/Lymphoma With Annular Skin Rash and Epidermotropism.

Am J Dermatopathol. 2018 Sep;40(9):676-678. doi: 10.1097/DAD.0000000000001113.

Stimulation of T-cell cytokine production and NK-cell function by IL-2, IFN-alpha and histamine treatment during remission of non-Hodgkin's lymphoma.

Hematol J. 2003;4(5):336-41. doi: 10.1038/sj.thj.6200320.

[Efficacy of modified Hyper-CVAD regimen on non-Hodgkin's lymphoma and safety evaluation].

Ai Zheng. 2009 Oct;28(10):1083-7. doi: 10.5732/cjc.009.10044.

[Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].

Ai Zheng. 2007 Apr;26(4):418-22.

引用本文的文献

An "off-the-shelf" CD2 universal CAR-T therapy for T-cell malignancies.

Leukemia. 2023 Dec;37(12):2448-2456. doi: 10.1038/s41375-023-02039-z. Epub 2023 Oct 5.

Cellular Therapy Updates in B-Cell Lymphoma: The State of the CAR-T.

Cancers (Basel). 2021 Oct 15;13(20):5181. doi: 10.3390/cancers13205181.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Immunotherapy for T-Cell ALL and T-Cell NHL.

作者信息

DiPersio John F, Staser Karl, Cooper Matthew

机构信息

Division of Oncology, Washington University School of Medicine, St Louis, MO, USA.

出版信息

Clin Lymphoma Myeloma Leuk. 2020 Sep;20 Suppl 1:S56-S58. doi: 10.1016/S2152-2650(20)30462-6.

DOI:10.1016/S2152-2650(20)30462-6

PMID:32862870

Abstract

摘要

相似文献

Immunotherapy for T-Cell ALL and T-Cell NHL.

Clin Lymphoma Myeloma Leuk. 2020 Sep;20 Suppl 1:S56-S58. doi: 10.1016/S2152-2650(20)30462-6.

Bispecific T-Cell Engager (BiTE) Antibody Construct Blinatumomab for the Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma: Final Results From a Phase I Study.

J Clin Oncol. 2016 Apr 1;34(10):1104-11. doi: 10.1200/JCO.2014.59.1586. Epub 2016 Feb 16.

CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies.

Blood. 2017 Jul 20;130(3):285-296. doi: 10.1182/blood-2017-01-761320. Epub 2017 May 24.

Head-to-head comparison of in-house produced CD19 CAR-T cell in ALL and NHL patients.

J Immunother Cancer. 2020 Mar;8(1). doi: 10.1136/jitc-2019-000148.

Activated T-cell-mediated immunotherapy with a chimeric receptor against CD38 in B-cell non-Hodgkin lymphoma.

J Immunother. 2009 Sep;32(7):737-43. doi: 10.1097/CJI.0b013e3181adaff1.

Chimeric antigen receptor T cells (CAR-T) for the treatment of T-cell malignancies.

Best Pract Res Clin Haematol. 2019 Dec;32(4):101097. doi: 10.1016/j.beha.2019.101097. Epub 2019 Oct 18.

T-Lymphoblastic Leukemia/Lymphoma With Annular Skin Rash and Epidermotropism.

Am J Dermatopathol. 2018 Sep;40(9):676-678. doi: 10.1097/DAD.0000000000001113.

Stimulation of T-cell cytokine production and NK-cell function by IL-2, IFN-alpha and histamine treatment during remission of non-Hodgkin's lymphoma.

Hematol J. 2003;4(5):336-41. doi: 10.1038/sj.thj.6200320.

[Efficacy of modified Hyper-CVAD regimen on non-Hodgkin's lymphoma and safety evaluation].

Ai Zheng. 2009 Oct;28(10):1083-7. doi: 10.5732/cjc.009.10044.

[Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].

Ai Zheng. 2007 Apr;26(4):418-22.

引用本文的文献

An "off-the-shelf" CD2 universal CAR-T therapy for T-cell malignancies.

Leukemia. 2023 Dec;37(12):2448-2456. doi: 10.1038/s41375-023-02039-z. Epub 2023 Oct 5.

Cellular Therapy Updates in B-Cell Lymphoma: The State of the CAR-T.

Cancers (Basel). 2021 Oct 15;13(20):5181. doi: 10.3390/cancers13205181.